Dynamite Blockchain Corp. — Capital/Financing Update 2026

Jan 27, 2026

{0}------------------------------------------------

August 12, 2020

VIA SEDAR

British Columbia Securities Commission (Principal Regulator) Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Manitoba Securities Commission Ontario Securities Commission Financial and Consumer Services Commission (New Brunswick) Nova Scotia Securities Commission Superintendent of Securities, Newfoundland and Labrador Superintendent of Securities, Prince Edward Island Autorité des marchés financiers (Quebec)

Dear Sirs and Mesdames:

Re: Emerald Health Therapeutics, Inc. (the "Company") - Prospectus Supplement dated August 12, 2020 (the "Prospectus")

We refer to the Prospectus relating to the qualification for distribution of common shares of the Company.

We hereby consent to the use of our firm's name on pages S-10 and S-35 of the Prospectus and under the headings "Eligibility for Investment" and "Legal Matters", which opinion is dated as of the date of the Prospectus.

We confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained in the Prospectus that is derived from our opinion referred to above, or that is within our knowledge, as a result of the services we performed in connection with such opinions.

Yours truly,

(signed) "Bennett Jones LLP"